The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family
Tóm tắt
Từ khóa
Tài liệu tham khảo
Romano, 2010, Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy, Atherosclerosis, 210
Pullinger, 1999, The apolipoprotein mutation characteristics of subjects from kindreds, J Lipid Res, 24, 3531
Romano, 2010, Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy, Atherosclerosis, 210
Sun, 2005, Evidence for effect of mutant on apolipoprotein secretion as the cause of unusually severe dominant hypercholesterolaemia, Hum Mol Genet, 14, 10.1093/hmg/ddi128
Minhas, 2009, Controversies in familial hypercholesterolaemia : recommendations of the NICE guideline development group for the identification and management of familial hypercholesterolaemia, Heart, 95
Minhas, 2009, Controversies in familial hypercholesterolaemia : recommendations of the NICE guideline development group for the identification and management of familial hypercholesterolaemia, Heart, 95
Romano, 2011, An improved method on stimulated T - lymphocytes to functionally characterize novel and known LDLR mutations, J Lipid Res, 2095, 10.1194/jlr.D017772
Tibolla, 2011, Proprotein convertase subtilisin / kexin type from structure function relation to therapeutic inhibition, Nutr Metab Cardiovasc Dis, 21, 835, 10.1016/j.numecd.2011.06.002
Gentile, 2008, dense LDL particles and metabolic syndrome in a sample of middle - aged women Findings from Progetto, Small Clin Chim Acta, 388
Sun, 2005, Evidence for effect of mutant on apolipoprotein secretion as the cause of unusually severe dominant hypercholesterolaemia, Hum Mol Genet, 14, 10.1093/hmg/ddi128
Pullinger, 1999, The apolipoprotein mutation characteristics of subjects from kindreds, J Lipid Res, 24, 3531
Wang, 2012, Molecular characterization of proprotein convertase subtilisin / kexin type mediated degradation of the LDLR, J Lipid Res, 53
Romano, 2011, An improved method on stimulated T - lymphocytes to functionally characterize novel and known LDLR mutations, J Lipid Res, 2095, 10.1194/jlr.D017772
Hopkins, 2011, DJ National lipid association expert panel on familial hypercholesterolemia Familial hypercholesterolemias prevalence genetics diagnosis and screening recommendations from the National lipid association expert panel on familial hypercholesterolemia, Clin, 9
Tibolla, 2011, Proprotein convertase subtilisin / kexin type from structure function relation to therapeutic inhibition, Nutr Metab Cardiovasc Dis, 21, 835, 10.1016/j.numecd.2011.06.002
Flanagan, 2010, Using SIFT and PolyPhen to predict loss - of - function and gain - of - function mutations Test, AM Genet Mol Biomarkers, 14, 533, 10.1089/gtmb.2010.0036
Wang, 2012, Molecular characterization of proprotein convertase subtilisin / kexin type mediated degradation of the LDLR, J Lipid Res, 53
Gentile, 2008, dense LDL particles and metabolic syndrome in a sample of middle - aged women Findings from Progetto, Small Clin Chim Acta, 388
Hopkins, 2011, DJ National lipid association expert panel on familial hypercholesterolemia Familial hypercholesterolemias prevalence genetics diagnosis and screening recommendations from the National lipid association expert panel on familial hypercholesterolemia, Clin, 9